Target intelligence / Profile preview

Hydroxylysine kinase (HYKK)

Target
HYKK
Molecular classification
Enzyme, Transferase, Phosphotransferase
01

Overview

Hydroxylysine kinase (HYKK) is an enzyme (EC 2.7.1.81) that catalyzes the phosphorylation of 5-hydroxy-L-lysine using GTP as a phosphate donor, forming GDP and 5-phosphonooxy-L-lysine[2][3]. It is encoded by the HYKK/AGPHD1 gene in humans[3][4]. This enzyme participates in the catabolism of hydroxylysine, a modified amino acid generated during collagen breakdown, and primarily functions in liver and kidney[3]. Deficiencies in hydroxylysine kinase are linked to rare inherited metabolic disorders such as hydroxylysinuria and hydroxylysinemia, with some patients displaying neurological symptoms, though disease causality remains under study[3]. Currently, hydroxylysine kinase is not a direct drug target and has no established interacting small molecules, but it is important in amino acid and connective tissue metabolism[2][3][4].

Other names
Guanosine triphosphate:5-hydroxy-L-lysine O-phosphotransferaseGTP:5-hydroxy-L-lysine O-phosphotransferaseHydroxylysine kinase (phosphorylating)
02

Mechanism of action

Catalyzes the GTP-dependent phosphorylation of 5-hydroxy-L-lysine, forming 5-phosphonooxy-L-lysine[2][3]

03

Biological functions

Lysine degradationAmino acid metabolismCollagen catabolism
04

Disease associations

Amino acid metabolic disorders (e.g., hydroxylysinuria, hydroxylysinemia)[3]Potential neurological involvement (reported in affected individuals)[3]
05

Safety considerations

No specific safety concerns or therapeutic challenges reported; deficiency may be associated with metabolic and possibly neurological symptoms[3]
06

Biomarkers

Elevated urinary 5-hydroxylysine (used as an index of collagen degradation but not specific to this enzyme)[1]Potential for 5-phosphohydroxylysine as a marker in research, but not clinically established[3]

Beyond the preview

Go deeper on Hydroxylysine kinase (HYKK).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Hydroxylysine kinase (HYKK).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call